Now is your chance to be part of the solution.

We are now a publicly traded company listed on the Toronto Stock Exchange Venture: TSX.V: IBO

We aim to provide safe, effective and affordable ibogaine treatment internationally.

Ibogaine – a molecule found in Tabernanthe iboga and other plants – offers the opportunity for a rapid detox, something current treatment options for opioid and other forms of addiction do not provide. In combination with an effective therapeutic setting, ibogaine offers the opportunity to live free from addiction. Our goal is to provide safe, effective and affordable ibogaine treatment internationally.

Join Our Mailing List For Updates

Market Overview

Sedar Filings

Why Did We Go Public?

To enable public participation in an ibogaine-focused company incorporating:

Media about Universal Ibogaine

  • Clinical Trials
    towards medicalization in Canada

  • Pre-Ibogaine treatment
    in Canada and other G7 locations

  • Exploration of Potential
    near term treatments in authorized locations

  • Holistic Treatment Programs
    for continued after-care

Recent News

Stay Up To Date

Analyst Coverage

Corporate Governance

Our mission is to be a respected and quality market leader in Canada’s addiction treatment industry.

Read about our corporate governance
Our Team
The Universal Ibogaine team is composed of experts from a variety of backgrounds and disciplines ensuring our strong medical expertise, clinic operations and capital market relationships puts us on a path for success.

View Our Company Profile

Board of Directors
Chief Ian Campbell
Chief Ian Campbell, MBA
Chairman (Independent)

Chief Ian Campbell, MBA - Chairman

Chief Ian Campbell (Xalek) is a hereditary chief of the Squamish Nation located in Vancouver, British Columbia. He has served as an elected member of council since 2005, and was appointed as a Political Spokesperson in 2008. Since 1999 he has been the Cultural Ambassador and Negotiator for the Intergovernmental Relations Department of the Squamish Nation, advancing Aboriginal rights and title, while invigorating substantive economic opportunities through negotiations, collaboration, and partnerships. Ian graduated from Simon Fraser University with an MBA in Aboriginal Business and Leadership.

Alberto Sola
Alberto Sola MD
Co-Founder and Director

Alberto Sola, MD - Co-Founder & President

Clear Sky Addiction Solution’s President, Dr Sola is a thought leader in entheogenic treatment. He has the distinction of having treated more patients with ibogaine than any other person in the world and is head of operations at Clear Sky Recovery. Dr. Sola graduated from Universidad Anahuac. As the Medical Director of Amerimed, he opened four emergency hospitals for tourists in Puerto Vallarta, Cancun, and Cabo San Lucas.

Anthony DeCristofaro
Anthony DeCristofaro

Anthony De Cristofaro - Director

Mr. DeCristofaro is currently CEO of Qnext Corp., a global developer of disruptive apps and private cloud technologies, and his extensive experience includes thirty years in the computer industry and three M&A transactions valued at more than $600 million. Over the course of his career, DeCristofaro has been sought out as a member of several high-profile public Boards, including Hartco, Delrina, Synchronica, and TransGaming. He also currently serves on the Board of Directors of Jack Nathan Medical Corp.

Nick Karos
Nick Karos

Nick Karos - Director

Nick is a major shareholder and Chief Executive Officer of Universal Ibogaine. Nick has enjoyed an illustrious career in corporate finance including leadership roles with Piper Jaffray and as CEO of Private Trading Group where he managed client portfolios and proprietary trading.

Robert Turner
Robert Turner, ICD.D, MBA
Director (Independent)

Robert Turner, ICD.D, MBA - Director

Mr. Turner is President of his own incorporated consulting firm and a Principal within Western Management Consultants (WMC). His consulting focus is providing guidance to Boards on their governance including proper CEO oversight. Mr. Turner brings experience as a CHRO in both the private and public sectors. Subsequently, he joined Mercer Canada as a Partner focused on consulting within Canadian health care. Robert has served on Universal Ibogaine’s Advisory Board since December 2018. Robert has an ICD.D certification from Rotman Business School, an MBA from the Ivey Business School and a BSc (Biochemistry) from the University of Toronto. He serves on the Boards of two other corporations – one private and one not-for-profit.



Contact Us

Up Arrow